Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/19/1991 | US5066782 Retrovirus capable of causing AIDS, means and method for detecting it in vitro |
11/19/1991 | US5066596 Bacterial strains harboring cloned genes controlling vibrio cholerae o-antigen biosynthesis |
11/19/1991 | US5066593 Synthetic peptide-based anti-rabies compositions and methods |
11/19/1991 | US5066592 Inhibition of fibrinogen induced aggregation of human platelets, anticoagulants |
11/19/1991 | US5066589 Plasmid derived form escherichia |
11/19/1991 | US5066588 Streptococcus lactis containing plasmids encoding for mucoidness and method for identifying such strains |
11/19/1991 | US5066581 Differentiation antigen, nda3, associated with the receptor for b cell growth factor |
11/19/1991 | US5066579 HTLV-I peptide antigen and assay |
11/19/1991 | US5066490 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
11/19/1991 | US5066487 Antisudoral composition comprising dibasic aluminium salts of acylated amino acids |
11/19/1991 | CA1292344C Peptides and therapeutic applications thereof |
11/19/1991 | CA1292343C Di- and tri-peptidal renin inhibitors |
11/19/1991 | CA1292236C Process for preparing n-alkylated amino acids and esters thereof |
11/19/1991 | CA1292200C Method for producing protein containing nonprotein amino acids |
11/18/1991 | WO1991018096A1 Methods for trans-destabilization of specific proteins in vivo |
11/18/1991 | WO1991018001A1 Trans-dominant suppressor genes for oligomeric proteins |
11/18/1991 | WO1991017665A1 Proteinaceous fat substitute |
11/18/1991 | CA2083164A1 Trans-dominant suppressor genes for oligomeric proteins |
11/18/1991 | CA2060655A1 Proteinaceous fat substitute |
11/17/1991 | WO1991017764A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
11/16/1991 | WO1991018102A1 Shuttle vector for recombinant bacillus thuringiensis strain development |
11/16/1991 | WO1991018019A1 Soluble single chain t cell receptors |
11/16/1991 | WO1991017823A1 Method and apparatus for biopolymer synthesis |
11/16/1991 | CA2047733A1 Soluble single chain t cell receptors |
11/16/1991 | CA2042569A1 Stabilized fgf composition |
11/16/1991 | CA2042437A1 Immunologic enhancement of the somatogenic effect of somatotrophin with an antibody |
11/16/1991 | CA2042295A1 Endogen mediator derivatives, salts thereof, process for their preparation, applications and compositions containing such |
11/16/1991 | CA2041446A1 Bacillus thuringiensis genes encoding novel dipteran-active toxins |
11/15/1991 | WO1991018099A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
11/15/1991 | WO1991018012A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
11/15/1991 | CA2059649A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
11/15/1991 | CA2042468A1 Compositions of and treatment with biologically active peptides having d-amino acid residues |
11/15/1991 | CA2042005A1 Plasmids, transformed animal cells and process for producing foreign protein |
11/14/1991 | WO1991017441A1 Analyte determination in biological fluids in the presence of interfering substances |
11/14/1991 | WO1991017439A1 Receptor assay for fk-506 |
11/14/1991 | WO1991017438A1 Novel gamma-aminobutyric acid/benzodiazepine receptor and method for determining steroid sites in a gbrc |
11/14/1991 | WO1991017271A1 Recombinant library screening methods |
11/14/1991 | WO1991017254A1 Method and means for extending the host range of insecticidal proteins |
11/14/1991 | WO1991017253A1 Mammalian cells expressing a hybrid receptor |
11/14/1991 | WO1991017249A1 Interleukin-1 antagonist and uses thereof |
11/14/1991 | WO1991017248A1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
11/14/1991 | WO1991017188A1 Separation of mammalian semen into fractions enriched either for spermatozoa containing an x chromosome or for spermatozoa contai ning a y chromosome |
11/14/1991 | WO1991017185A1 Plaque-inhibiting protein from bacteroides loeschei and methods for using the same |
11/14/1991 | WO1991017184A1 Modified interleukin-1 inhibitors |
11/14/1991 | WO1991017183A1 Proteins with fibroblast growth factor receptor activity |
11/14/1991 | WO1991017182A1 Human and rat thymopoietin |
11/14/1991 | WO1991017180A1 Peptides derived from human tumour necrosis factor alpha and useful against intracellular malarial parasites |
11/14/1991 | WO1991017179A1 Peptide analogs to proteins of the immunoglobulin superfamily |
11/14/1991 | WO1991017178A1 Method for purifying recombinantly-produced proteins |
11/14/1991 | WO1991017174A1 Dna encoding human 5-ht1d receptors and uses thereof |
11/14/1991 | WO1991017171A1 NUCLEOTIDE SEQUENCE ENCODING A 52 kDa Ro/SSA AUTOANTIGEN |
11/14/1991 | WO1991016925A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines |
11/14/1991 | WO1991016922A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
11/14/1991 | WO1991016919A1 Synthetic peptides for arterial imaging |
11/14/1991 | WO1991015222A3 Method of predisposing mammals to accelerated tissue repair |
11/14/1991 | WO1991014706A3 Lectin affinity membranes and methods for using them |
11/14/1991 | WO1991014704A3 Treatment of polycystic ovarian disease |
11/14/1991 | DE4014510A1 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie Variant CD44-oberflaechenproteine, this encoding c-dna sequences, antibodies against these proteins and their use in the diagnosis and therapy |
11/14/1991 | CA2374571A1 Dna encoding human 5-ht1d receptors and uses thereof |
11/14/1991 | CA2081774A1 Interleukin-1 antagonist and uses thereof |
11/14/1991 | CA2080493A1 Synthetic peptides for arterial imaging |
11/13/1991 | EP0456524A1 Method for assaying antibody against Chlamydia Trachomatis and diagnostic preparation for Chlamydia Trachomatis infection |
11/13/1991 | EP0456332A1 Purified interleukin 1 and DNA coding for interleukin 1 and their preparation, vectors containing such DNA and their preparation and use in transforming hosts to permit expression of interleukin 1 |
11/13/1991 | EP0456304A1 Preparation and isolation of single-stranded biotinylated nucleic acids by avidin-biotin cleavage |
11/13/1991 | EP0456200A1 Mutein of granulocyte colony stimulating factor (G-CSF) |
11/13/1991 | EP0456197A1 Seroreactive epitopes from proteins of human papilloma virus (HPV) 18 |
11/13/1991 | EP0456188A1 Therapeutic agent for hepatocirrhosis |
11/13/1991 | EP0456185A2 Renin inhibitors |
11/13/1991 | EP0456152A2 Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors |
11/13/1991 | EP0456093A2 Biguanide derivatives and biocidal compositions containing them |
11/13/1991 | EP0456039A2 Renin inhibiting amino acid derivatives |
11/13/1991 | EP0455741A1 Method for detecting inhibitors of tat protein |
11/13/1991 | EP0455722A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them |
11/13/1991 | EP0455690A1 Inhibition of plant cell respiration |
11/13/1991 | EP0455682A1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides. |
11/13/1991 | EP0455668A1 Male flower specific gene sequences |
11/13/1991 | EP0455666A1 Regulation of plant gene expression |
11/13/1991 | EP0455665A1 Hybrid seed production |
11/13/1991 | EP0444129A4 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
11/13/1991 | EP0422049A4 Vector for secretion of proteins directly into periplasm or culture medium |
11/13/1991 | EP0420911A4 Gene therapy using gene fusions for genetic or acquired disorders |
11/13/1991 | EP0412115A4 Hybrid peptides and methods of their use |
11/13/1991 | EP0236385B1 A superoxide dismutase |
11/13/1991 | EP0180596B1 Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelet with vessel walls |
11/13/1991 | EP0152468B1 Production of streptococal m protein immunogens and molecular probes |
11/13/1991 | CN1056125A Soluble, truncated gamma-interferon receptors |
11/12/1991 | WO1991018118A1 Papillomavirus probe (hpv66), particularly for the diagnosis in vitro of papillomavirus infections which may be accompanied by genital neoplasia, and products genetically and immunologically related to said papillomavirus |
11/12/1991 | WO1991018101A1 Process for producing protein |
11/12/1991 | WO1991018100A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
11/12/1991 | US5064943 Basic PH to dissolve refractile bodies |
11/12/1991 | US5064942 New protein tetranectin isolated from human blood |
11/12/1991 | US5064941 Collagen extracted from collagen-containing tissue |
11/12/1991 | US5064939 Cyclic gnrh antagonists |
11/12/1991 | US5064817 Phospholipase a2 inhibiting compositions and their use |
11/12/1991 | US5064759 Novel biological polymer |
11/12/1991 | US5064757 T4 DNA fragment as a stabilizer for proteins expressed by cloned DNA |
11/12/1991 | US5064657 Spider toxins and methods for their use as blockers of amino acid receptor function |
11/12/1991 | US5064648 Use of Bacillus thuringiensis microbe for controlling lesser mealworm, Alphitobius diaperinus |
11/12/1991 | US5064646 In poultry, which will not bind to monoclonal antibodies that bind to current vaccines; live or killed vaccines |
11/12/1991 | US5064430 Polynonapeptide bioelastomers having an increased elastic modulus |